Kosmas I. Paraskevas

Understanding the bias in machine learning systems for cardiovascular disease risk assessment: The first of its kind review

2022 · 79 Zit. · Computers in Biology and Medicine

A Pharmaceutical Paradigm for Cardiovascular Composite Risk Assessment Using Novel Radiogenomics Risk Predictors in Precision Explainable Artificial Intelligence Framework: Clinical Trial Tool

2023 · 12 Zit. · Frontiers in Bioscience-Landmark

Personalized Medicine for Cardiovascular Disease Risk in Artificial Intelligence Framework

2023 · 5 Zit. · Research Square (Research Square)

Applications of Artificial Intelligence in Vascular Diseases

2022 · 5 Zit. · Angiology